The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Initial results from a first in human trial incorporating accelerated dose titration of a novel immune stimulating oncolytic virus - VG161.
 
Ronghua Zhao
Employment - Virogin Biotech
Leadership - Virogin Biotech
Stock and Other Ownership Interests - Virogin Biotech
 
Rasha Cosman
Research Funding - Multiple role as PI (Inst)
 
Neha Aggarwal
No Relationships to Disclose
 
Aaron O'Grady
No Relationships to Disclose
 
Eugene Hsu
No Relationships to Disclose
 
Luke Ardolino
No Relationships to Disclose
 
Huiqun Xia
Employment - Virogin Biotech
Stock and Other Ownership Interests - Virogin Biotech
 
Yiting Chi
Employment - Virogin Biotech
 
Shi Qui
Employment - CNBG/Virogin Viotech; Virogin Biotech (I)
 
Yanal Murad
Employment - Virogin Biotech
Patents, Royalties, Other Intellectual Property - Virogin Biotech
 
Erica Lee
Employment - Virogin Biotech
 
William Jia
Employment - Virogin Biotech
Leadership - Virogin Biotech
Stock and Other Ownership Interests - Virogin Biotech
Patents, Royalties, Other Intellectual Property - Virogin Biotech
 
Anthony M. Joshua
Consulting or Advisory Role - AstraZeneca (Inst); Ipsen (Inst); IQvia (Inst); Janssen Oncology (Inst); Neoleukin Therapeutics (Inst); Novartis (Inst); Noxopharm (Inst); Pfizer (Inst); Sanofi (Inst)
Research Funding - AstraZeneca (Inst); Bayer (Inst); Bristol-Myers Squibb (Inst); Corvus Pharmaceuticals (Inst); Janssen Oncology (Inst); Lilly (Inst); Lilly (Inst); Macrogenics (Inst); Mayne Pharma (Inst); Merck Sharp & Dohme (Inst); Pfizer (Inst); Roche/Genentech (Inst)